Johnson & Johnson (JNJ)

EBITDA Growth

-22.11%

TTM · Period ending:

JNJ logo

JNJ EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-22.11%
JNJ TTM EBITDA YoY % (29.96% → -22.11%)
High-resolution chart · PNG

JNJ ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Johnson & Johnson EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
12.0094%
10.3579%
10.418%
9.3273%
9.8725%
12.6674%
14.2536%
18.6139%
23.0641%
19.2321%
15.3939%
10.5818%
5.3631%
4.8077%
5.5434%
7.0971%
7.7696%
13.7303%
17.2296%
20.0995%
26.6075%
22.7137%
23.1701%
25.1911%
23.2771%
26.0257%
22.9524%
17.2975%
14.649%
8.6794%
6.5908%
6.1685%
4.0946%
7.1481%
7.9732%
6.7746%
4.5387%
4.2982%
3.7896%
5.2277%
14.1533%
12.5428%
-35.8949%
-35.7016%
225.211%
1,138.2222%
1,341.2308%
179.7009%
-193.625%
-112.3674%
-121.1135%
16.1194%
18.3923%
21.319%
25.9759%
22.926%
28.2811%
29.9593%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.